Results 41 to 50 of about 16,340 (253)

Factors impacting survival after transarterial radioembolization in patients with hepatocellular carcinoma: Results from the prospective CIRT study

JHEP Reports, 2022
Background & Aims Transarterial radioembolization (TARE) with Yttrium-90 resin microspheres is an established treatment option for patients with hepatocellular carcinoma (HCC).
F. Kolligs, D. Arnold, R. Golfieri, M. Pech, B. Peynircioğlu, T. Pfammatter, M. Ronot, B. Sangro, N. Schaefer, G. Maleux, G. Munneke, H. Pereira, B. Zeka, N. de Jong, T. Helmberger, T. Albrecht, Vivantes Klinikum Neukölln, O. D'archambeau, T. Ballı, S. Bilgiç, Allan Bloom, R. Cioni, R. Fischbach, A. Altona, P. Flamen, L. Gérard, G. Grözinger, M. Katoh, M. Koehler, J. Kröger, C. Kuhl, F. Orsi, M. Özgün, P. Reimer, M. Ronot, A. Schmid, A. Vit   +36 more
semanticscholar   +1 more source

Side Effects of Yttrium-90 Radioembolization

Frontiers in Oncology, 2014
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj   +1 more source

Updated management of malignant biliary tract tumors: an illustrative review [PDF]

, 2016
The management of malignant biliary tumors (MBTs) is complex and requires a multidisciplinary approach. Guidelines and methods of staging for biliary tumors have recently been released by main international societies, altering the clinical and radiologic
Cannavale, Alessandro, Catalano, Carlo, Fanelli, Fabrizio, Fiocca, Fausto, Gazzetti, Marianna, Maher, Ben, Santoni, Mariangela   +6 more
core   +1 more source

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

JAMA Oncology, 2020
Importance Patients with unresectable intrahepatic cholangiocarcinoma (ICC) have a poor prognosis. Selective internal radiotherapy (SIRT) is a promising treatment option for hepatic tumors, but no prospective studies of combination SIRT with chemotherapy
J. Edeline, Y. Touchefeu, B. Guiu, O. Farge, D. Tougeron, I. Baumgaertner, A. Ayav, B. Campillo-Gimenez, L. Beuzit, M. Pracht, A. Lièvre, S. le Sourd, K. Boudjema, Y. Rolland, E. Boucher, E. Garin   +15 more
semanticscholar   +1 more source

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study

European Journal of Nuclear Medicine and Molecular Imaging, 2022
To investigate the relationships between tumor absorbed dose (TAD) or normal tissue absorbed dose (NTAD) and clinical outcomes in hepatocellular carcinoma (HCC) treated with yttrium-90 glass microspheres.
M. Lam, E. Garin, M. Maccauro, S. Kappadath, D. Sze, C. Turkmen, M. Cantaşdemir, Paul Haste, K. Herrmann, H. Alsuhaibani, M. Dreher, K. Fowers, R. Salem   +12 more
semanticscholar   +1 more source

First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI) [PDF]

, 2012
The objective of this pilot clinical study was to assess the safety, technical feasibility, pharmacokinetic (PK) profile and tumour response of DC Bead™ with irinotecan (DEBIRI™) delivered by intra-arterial embolisation for the treatment of metastatic ...
Eichler, Katrin, Gallus, Christof, Gruber-Rouh, Tatjana, Hammerstingl, Renate Maria, Mack, Martin G., Vogl, Thomas J., Zangos, Stephan   +6 more
core   +1 more source

Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study

Journal of Nuclear Medicine, 2022
Visual Abstract The safety and efficacy of 166Ho radioembolization was first determined in the HEPAR and HEPAR II studies, which, however, excluded patients with hepatocellular carcinoma (HCC).
Margot T M Reinders, K. V. van Erpecum, M. Smits, A. Braat, J. de Bruijne, R. Bruijnen, D. Sprengers, R. D. de Man, E. Vegt, J. Ijzermans, A. Moelker, M. Lam   +11 more
semanticscholar   +1 more source

Biology of advanced uveal melanoma and next steps for clinical therapeutics [PDF]

, 2014
Uveal melanoma is the most common intraocular malignancy although it is a rare subset of all melanomas. Uveal melanoma has distinct biology relative to cutaneous melanoma, with widely divergent patient outcomes.
Bastian, BC, Bowcock, AM, Carvajal, RD, Flaherty, KT, Gershenwald, JE, Gutkind, JS, Luke, JJ, McKenna, KC, Patel, PM, Sato, T, Selig, S, Sossman, JA, Streicher, HZ, Sznol, M, Thurin, M, Triozzi, PL, Van Meir, EG, Welch, J   +17 more
core   +1 more source

Comparison of MRI-based response criteria and radiomics for the prediction of early response to transarterial radioembolization in patients with hepatocellular carcinoma.

Diagnostic and Interventional Imaging, 2022
PURPOSE The purpose of this study was to evaluate the capabilities of radiomics using magnetic resonance imaging (MRI) data in the assessment of treatment response to 90yttrium transarterial radioembolization (TARE) in patients with locally advanced ...
Godefroy Aujay, Christèle Etchegaray, J. Blanc, B. Lapuyade, P. Papadopoulos, Marie-Anaïg Pey, L. Bordenave, H. Trillaud, Olivier Saut, J. Pinaquy   +9 more
semanticscholar   +1 more source

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy

Case Reports in Radiology, 2012
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy, Terence W. Hughes, Mohit Gupta, Josephina A. Vossen, Noel B. Velasco, Kenneth M. Zinn   +5 more
doaj   +1 more source